Long-Acting Peptide Drug
Frontier Biotech has established an extraordinarilytalented R&D teamwith deep expertise
and extensive experience in all aspects of new drug development. Successful development
and launch of Aikening ? have enabled Frontier
Biotech to develop a state-of-the-art platform for the advancement of long-acting
peptide drug innovation, which in turn lays a solid foundation for expandingour
product portfolio and further strengtheningFrontier's global competence.